MDB Capital Holdings LLC Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Total Operating Income Quarterly-103K
Net Loss Quarterly-6.7M
Cash and Current Assets (Net of Liabilities) Annually22.3M
Watch Items
- Spin-out of PatentVest and MDB Direct (Public Ventures clearing platform)Trigger: Completion of independent spin-outs or strategic partnershipsAction: Monitor reduction in annual fixed operating expenses toward the targeted $6 million run-rate.
- Paulex Bio Clinical Trial and IPOTrigger: Clinical trial initiation in late 2026 and targeted IPO in September 2026Action: Track development milestones and valuation impact on MDB's 7.1 million shares and warrants.
- eXoZymes (EXOZ) Valuation and LiquidityTrigger: Fluctuations in EXOZ stock price and proposed $15 million public offeringAction: Assess the carrying value of MDB's 4.1 million shares and warrants, and monitor underwriting fees generated by Public Ventures.
Research as of 20 Jun 2026